Mironid
Company

Last deal

Amount

Venture - Series Unknown

Stage

01.01.2018

Date

2

all rounds

$6.2M

Total amount

General

About Company
Mironid develops drugs for kidney diseases, inflammation, and cancer.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2014

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

Mironid Limited is a developer of therapeutics drugs that aims to improve the health and quality of life of patients by creating high-value therapeutics addressing global unmet medical needs. The company develops proprietary drugs by modulating the activity of key cell-signaling proteins, which allows access to multiple therapeutic areas for exploitation. Mironid's current drug discovery pipeline is aimed at developing novel treatments for degenerative kidney diseases, chronic inflammatory diseases, and cancer. Google Analytics is used to track and examine the use of Mironid's website, with the data collected being utilized to contextualize and personalize the ads of its own advertising network.
Contacts